Naveen Pemmaraju | MD Anderson Cancer ...

Dr. Naveen Pemmaraju, MD

Claim this profile

MD Anderson Cancer Center

Studies Cancer
Studies Blastic Plasmacytoid Dendritic Cell Neoplasm
11 reported clinical trials
27 drugs studied

Area of expertise

1Cancer
Naveen Pemmaraju, MD has run 7 trials for Cancer. Some of their research focus areas include:
Stage I
CD123 positive
Stage II
2Blastic Plasmacytoid Dendritic Cell Neoplasm
Naveen Pemmaraju, MD has run 5 trials for Blastic Plasmacytoid Dendritic Cell Neoplasm. Some of their research focus areas include:
CD123 positive
Stage I

Affiliated Hospitals

Image of trial facility.
M D Anderson Cancer Center
Image of trial facility.
M D Anderson

Clinical Trials Naveen Pemmaraju, MD is currently running

More about Naveen Pemmaraju, MD

Clinical Trial Related5 years of experience running clinical trials · Led 11 trials as a Principal Investigator · 2 Active Clinical Trials
Treatments Naveen Pemmaraju, MD has experience with
  • Venetoclax
  • Cyclophosphamide
  • Cytarabine
  • Azacitidine
  • Fludarabine
  • Dexamethasone

Other Doctors you might be interested in

Frequently asked questions

Do I need insurance to participate in a trial?
What does Naveen Pemmaraju, MD specialize in?
Is Naveen Pemmaraju, MD currently recruiting for clinical trials?
Are there any treatments that Naveen Pemmaraju, MD has studied deeply?
What is the best way to schedule an appointment with Naveen Pemmaraju, MD?
What is the office address of Naveen Pemmaraju, MD?
Is there any support for travel costs?
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security